secwatch.observer — SEC 8-K summary
======================================

Issuer:     Structure Therapeutics Inc. (GPCR)
CIK:        0001888886
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001104659-23-011717
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Structure Therapeutics adopts restated articles authorizing 500M ordinary shares, effective upon IPO closing
--------------------------------------------------------------------------------

- Filed restated memorandum and articles on Feb 3, 2023, effective Feb 7, 2023 upon IPO closing.
- Authorizes 500,000,000 ordinary shares; details previously reported in Registration Statement on Form S-1.
- Seventh amended and restated memorandum and articles of association filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/0001104659-23-011717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/tm235639d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-011717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer